How to Start a Supplement Brand in Europe (2026 Guide)
Niche, formulation, manufacturer, MOQs, costs, timelines and EU compliance, the full playbook for launching a nutraceutical brand in Europe in 2026.
Starting a supplement brand in Europe in 2026 is genuinely easier than it was five years ago, stock formulations are deeper, low-MOQ contract manufacturers will quote 1,000-unit runs, and consumers actually expect to buy from indie brands. It is also more regulated, more competitive, and more capital-sensitive than most founders assume. This guide walks the full launch path: niche, format, manufacturer, MOQ, cost, timeline, and the EU compliance work you cannot skip.
1. Pick a niche that has a buyer, not just a trend
Most failed supplement launches die at the niche step. A profitable niche has three things at once: a defined target buyer, a measurable problem that buyer already spends money on, and enough search demand or community to reach the buyer without burning through paid media.
Strong 2026 EU niches: women's perimenopause support, gut-and-skin, longevity stacks (NMN, spermidine, urolithin A where permitted), strength-and-recovery for amateur athletes, focus/cognition for knowledge workers, and condition-specific iron and magnesium for women. Avoid generic multivitamins, generic protein, and generic collagen unless you have a real distribution edge, they are saturated and price-driven.
2. Choose your route: white label, private label, or custom
The three routes are not interchangeable. Pick the one that matches your runway and brand thesis.
- White label, buy an off-the-shelf formula, put your label on it. MOQ from 500–2,000 units, lead time 4–8 weeks. Fastest, cheapest, least differentiated.
- Private label, a stock base formula tweaked for you (different active dose, added ingredient, your flavour). MOQ 2,000–10,000 units, 10–16 weeks. Best balance for most launches.
- Custom / contract manufacturing, formulation built from scratch with stability testing. MOQ 5,000–50,000 units, 5–9 months, 4,000–12,000 EUR in R&D before you make a single bottle.
3. Choose the format before the formula
The format dictates MOQ, cost-per-unit, equipment, and which manufacturers can even quote you. Pick deliberately:
- Capsules and tablets, broadest manufacturer base, lowest MOQ, easiest to ship.
- Softgels, best for oils (omega-3, vitamin D, CoQ10). MOQ usually 10,000+.
- Gummies, high consumer pull, high MOQ (25,000+ typical), thermal limits on heat-sensitive actives.
- Powders and sticks, best for protein, creatine, electrolytes, greens. Lower MOQ for jars, higher for sachets.
- Liquids and shots, premium feel, complex shelf-life, MOQ 5,000+, glass and cold-chain risk.
4. Find a manufacturer that fits your stage
The biggest sourcing mistake is talking to large contract manufacturers when you need a 1,500-unit launch run. They will quote you, but you will be deprioritised the moment a 50,000-unit client books a line. Match the CMO to the order size.
- Decide the country. Italy and Germany dominate EU capsule and tablet manufacturing; Spain and Portugal are strong on liquids and gummies; the Netherlands and Belgium are strong on premium softgels. Manufacturing inside the EU avoids customs friction and simplifies compliance.
- Verify GMP. Ask for the current EU GMP or national food-supplement GMP certificate plus ISO 22000 / FSSC 22000. Cross-check on the registrar's database.
- Demand a sample CoA. A serious CMO will share a redacted Certificate of Analysis from a recent batch. No CoA, no contract.
- Get a line-item quote. Ingredients, manufacturing, primary packaging, secondary packaging, QC. A single bundled per-unit number is a negotiating dead end.
5. Understand MOQ and cost reality
For a 60-capsule SKU on a stock formula, expect ex-works cost between 1.20 EUR and 3.50 EUR per bottle at 5,000 units. The cost curve is steep: the same SKU at 25,000 units typically drops to 0.80–2.20 EUR. At 1,000 units (low-MOQ), per-unit cost is often 30–80% higher than at 5,000 units. That is the price of testing a SKU before you commit cash to inventory.
Add to ex-works: shipping inside the EU (0.20–0.60 EUR per unit at pallet scale), warehousing and pick-pack if you are 3PL'd (1.50–3.50 EUR per order), payment processing (1.5–3%), and your blended marketing cost per acquisition. Most viable supplement brands target a 4–5x markup from ex-works to retail.
6. Plan a realistic timeline
- Weeks 0–2, niche, format, brand name, EU entity decision.
- Weeks 2–6, manufacturer shortlist, sample requests, NDAs, quote comparison.
- Weeks 4–10, formulation lock, artwork, label compliance check, country notification dossier.
- Weeks 8–16, production run, QC release, freight to 3PL.
- Weeks 12–20, launch.
7. EU compliance basics you cannot skip
Food supplements in the EU are regulated under Directive 2002/46/EC plus the general food law (Regulation 178/2002), labelling (1169/2011), and health claims (1924/2006). A few non-negotiables for any new brand:
- Food Business Operator (FBO) in the EU. Required to place product on the market.
- Country notification. Italy, France, Belgium, Spain, Portugal, Greece, and most CEE markets require notifying the competent authority before sale. Germany does not pre-notify but enforces strictly post-market.
- Health claims. Only EFSA-authorised claims can appear on the label or marketing. "Boosts immunity" is illegal; "Vitamin C contributes to the normal function of the immune system" is fine if the product hits the 15%-NRV threshold.
- Novel foods. Ingredients not consumed significantly in the EU before May 1997 (e.g. NMN, certain mushroom extracts, CBD isolates) need novel food authorisation. Check the EU Novel Food Catalogue before formulating.
- Maximum levels. Several member states set national maximums per nutrient. A formula compliant in Spain can be non-compliant in France.
8. Build for the second SKU before launching the first
Single-SKU supplement brands are hard to grow because customer lifetime value is capped at one product. Pick a first SKU with an obvious second and third, a sleep stack, a recovery stack, a hormone-support range. The first product is a wedge, not the business.
The shortcut
Steps 4 and 5 above, finding and vetting a CMO that fits your stage, are where most founders lose two to four months. Jake exists specifically to compress that step. Send him your format, MOQ, ingredient list and target market on WhatsApp, and he comes back with pre-vetted EU manufacturers and real quotes, usually within a business day.
FAQ
How much money do I need to launch a supplement brand in Europe?
Realistic minimum is 8,000–20,000 EUR for a first SKU on a stock formulation at 1,000–3,000 units, including artwork, samples, compliance notification, and a small launch inventory. A custom-formulated SKU at 5,000–10,000 units is typically 25,000–60,000 EUR before marketing.
How long does it take to launch from idea to first sale?
On a stock white-label formulation: 6–10 weeks. On a private-label adjustment of an existing formula: 10–16 weeks. On a fully custom formulation with stability testing: 5–9 months. The country notification step adds 0–8 weeks depending on member state.
Do I need a company in the EU to sell supplements there?
You need a 'food business operator' established in the EU who is legally responsible for the product. That can be your own EU entity or, in some setups, your manufacturer or an importer of record. Selling D2C into the EU from outside without an FBO in the EU is not compliant.
Should I start with private label or develop my own formula?
Almost always start with private label or a lightly modified stock formula. It cuts time-to-market by 4–6 months and capital risk by 60–80%. Validate the SKU sells, then reinvest into a proprietary formulation.
Tell Jake what you're building, format, ingredients, target MOQ, market. You get 2–4 pre-vetted EU suppliers with real offers, usually within a business day. Free.